chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client presented to the vaccination site on 11/11/2021. The patient notified PHN that she had received a single dose of Pfizer COVID vaccine (lot EN6199) on 03/09/2021. Patient reported that 8 hours after receiving the vaccine, she woke up with sharp chest pain, shortness of breath, headache, and nausea. She went to the ER where she remained in observation for 3 hours before being cleared. The patient denies having received oxygen and no arrhythmias reported. The patient returned to the ER 3 days later for the same symptoms and remained in observation for 1 hour before being cleared. The patient had cardiac testing done with a Holter monitor that resulted in no cardiac diagnosis. Patient reports her chest pain resolved in 2 months and her headache resolved in 3 months. Patient reported her primary provider diagnosed the reaction as an allergy to PEG. The patient reported contact allergy to PEG causing itchy rach. Patient reported other allergies to penicillin causing fainting, and ibuprofen causing nausea, vomiting, and headache. Patient denies medical conditions and takes no medications. PHN submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Janssen. Per authority guidance, approval to proceed with COVID vaccine Janssen was obtained from medical consult team via text message, Vaccine Operations Lead, per (Privacy). Client received COVID vaccine Janssen (lot 1855194) on 11/12/2021. The client did not report any symptoms during the 30 minute observation period. RN educated client on possible adverse reactions and when to seek medical care. The client left the vaccination site at 1135 walking with steady gait.
Initial information received from a healthcare professional on 30 September 2014. An unidentified female patient (date of birth not reported) with a history of egg and gelatin allergy and asthma was vaccinated on an unspecified date with FLUZONE Trivalent, batch, and route of administration were not reported. At an unspecified time in 2012, the patient experienced anaphylaxis which required an EPIPEN treatment. The patient's concomitant medications were not reported. The patient was being desensitized at an allergist office, but no other information was given. The patient outcome was recovered. Documents held by sender: None.
day 9 & day 10 p/vax broke out in fine rash then day 11 & 12 hives; target rash swollen joints; tx w/DPH dx w/serum sickness disease;
eight days after vaccine woke up with red raised patch going from injection site down arm just a skinny stripe. It was hot to touch. Felt like i got stung by a bee. Today it is still red, slight less hot and swollen. Have not taken any medications.
Patient received flu vaccine (FLUVIRIN) Lot 158202 Novartis in right upper arm on 10/23/15 complains of arm soreness 11/6/15.
On 06/11/2000 the patient developed chicken pox. The patient sought unspecified medical treatment. Addtional information has been requested.
Patient got Covid after my 3rd or 4th dose of Moderna.; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Patient got Covid after my 3rd or 4th dose of Moderna.) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient got Covid after my 3rd or 4th dose of Moderna.). At the time of the report, COVID-19 (Patient got Covid after my 3rd or 4th dose of Moderna.) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
This spontaneous report was received from a physician and refers to a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patient was vaccinated with first and second dose of M-M-R II (lot #, dose, route of administration and anatomical location were not provided). On an unknown date, the patient had titers drawn which showed he was negative for measles. The outcome of the event was unknown. The relatedness between the event and M-M-R II was not reported. Additional information is not expected, as no contact details were provided.
Loss of balance/equilibrium x2 days after immunization. Deep ache across back of waist line for 21 week after immunization.
Day of vaccine low grade temp. Day after vaccine fatigue and site discomfort. Day 3 large lump at inj site painful and itchy. Painful shoulder to elbow. Rx for cellulitis 12/7-17. Improved 12/8/17.
Symptoms: hallucination, tired, weakness, scream in her sleep. Treatment: patient went to urgent care and later was seen by primary care physician for lab work. Her primary doctor prescribed her sleep aid and electrolytes.
"HPI 30 year old female complaining of had J&J vaccine yesterday. This morning was lying down because of the body aches and she started with sharp chest pain and can not get a full breath in it is still there if she tries to take a deep breath no fever no chills she did have body aches after the vaccine no NVD she has a migraine headache that started last night with a regular headache last night this morning with migraine"
Patient admitted for cc of progressive weakness and numbness for 1 week prior to admission.  She had hx of scleroderma, Raynaud's phenomenon, glaucoma, pulmonary fibrosis, hypothyroidism, and had received the influenza vaccine 2-3 weeks prior to admission.  Along with hx of progressive weakness and numbness, pt showed elevated protein in CSF consistent with Guillain-Barre Syndrome  Pt was treated with 5 days of intravenous immune globulin in addition to supportive care.  Her weakness slowly resolved with IVIG therapy and she was discharged to rehab hospital. Infoiration received from discharge summary states vision change. msv
Reaction to PREVNAR 13. Known reaction with redness, swelling and pain localized around injection site area for past 4-5 days and since vaccine.
Pt reports adverse reaction with swelling to arm and flu like symptoms after receiving H1N1 vaccine.  Reports was hospitalized at Medical Center and discharged on Tamiflu.  11/20/09:  ED Record, Discharge Summary and medical records received for dates of service 11/7/09 to 11/8/09.  Final Dx:  Viral syndrome vs. adverse reaction to H1N1 vaccination.  Assessment:  Presents with flu like symptoms of fever, chills, HA, and fatigue, cough, malaise, diaphoresis, R sided chest pain.  BP 158/114.  Started on Tamiflu.  IV fluids administered.  Axillary lymphadenopathy.  Sx. nearly resolved overnight, pt. d/c'd to home.
Patient received flu vaccine and reported her arm hurt and was sore for 5 days. She felt it was unusual because she did not have such extended arm soreness when she had flu shots in the past.
On day 7 I noticed 1-2 enlarged lymph nodes in my collarbone on my right side. On day 8 it got a little bigger. On day 9 it stayed the same. On day 10 it has not reduced in size. It is soft and movable, but still there. It is mildly uncomfortable. I am aware of it, because my bra strap hits it throughout the day.
Onset 1 hr. post injection - facial itching - PO BENADRYL 25mg 2 hrs. after injection - left sided facial swelling - no airway obstruction - BENADRYL 50 mg IM with no relief. Taken to ER via ambulance discharged same day.
No adverse effect, but an error in administration. Patient is under 18 years old received Moderna Vaccine. At the time of vaccination it was understood that in this area , anyone 16 and older could receive Moderna. Since it was pointed out by the health facility stopped vaccinating 16 to 18 year olds with Moderna.
WARMTH AT INJECTION SITE; ITCHING AT INJECTION SITE; HEADACHE; SWELLING AT INJECTION SITE; RED DISCOLORATION  AT INJECTION SITE; BODY ACHES; FATIGUE; This spontaneous report received from a patient concerned a 33 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: 21-JUN-2021) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced fatigue. On 10-APR-2021, the subject experienced warmth at injection site. On 10-APR-2021, the subject experienced itching at injection site. On 10-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced swelling at injection site. On 10-APR-2021, the subject experienced red discoloration at injection site. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and fatigue on 09-APR-2021, and headache on 11-APR-2021, and had not recovered from swelling at injection site, red discoloration at injection site, itching at injection site, and warmth at injection site. This report was non-serious.
was exposed to a friend that was tested positive for COVID on Wednesday. It has been almost 8 days later that she was exposed and her mother in law is experiencing some symptoms; This is a spontaneous report from a contactable consumer. This consumer reported for an unspecified age of female patient. A female patient with unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on an unspecified date as dose 1, single for COVID-19 immunization. On an unspecified date, after the vaccination, the patient exposed to a friend who was tested positive for COVID on Wednesday. It has been almost 8 days later that the patient was exposed and the patient was experiencing some symptoms. Caller was wondering if the patient needs to get tested for COVID. The outcome of the event was unknown.  No follow-up attempts possible. No further information expected.
shortly p/vax pt turned to the rt groaned & went unconscious, eyes open, glassy eyed, did not respond to name, body went rigid, dizzy, extreme ringing in ears, crying, breathing erratically;
Pt exp erythema & edema of lt upper arm & to 1inch above elbow. Lasted 2-3 day.
Itching originally, scratched at it, then 2 days later with extensive redness/swelling/induration over prominent excoriations, concern for cellulitis and treated with KEFLEX.
8.5 cm X 3 cm area of tan/lt. brown pigmentation of thigh where shot administered
I had horribly painful flu like symptoms: severe, severe, muscle aches all over my body, chills, sore throat and fever.
Joint pain specifically on the left side.  Left neck, shoulder, and hip pain since vaccine was given.  My neck and spine have been stiff and sore since the vaccine.  I am unable to complete upper body workouts due to the pain after lifting even 10 lbs.  I was healthy and athletic prior to the vaccine and will not continue the shot sequence. There is not enough data on this vaccine to determine the long term effects of administration. I should have never received the 1st shot.
-My son had 1st dose on 15th june afternoon 12.40 pm. -on 16th june early morning 2 am , he complained of chest pain and breathing problems - in the morning around6 am on 16th june, we took him to seattle children hospital emergency ward -doctors done few testings ekg, blood test, xray -meanwhile doctors gave Ibuprofen tablet to my son. -after 1 hours my son told pain was reduced. -again doctors gave ibuprofen tablet -around 11-12 pm afternoon on 16th june, my son told, almost chest pain and breathing problem gone. -we discharged from hispital
Achy muscles; Achy muscles, esp. near injection site; Mild nausea; Very, very fatigued; Feeling cold; Flu like symptoms; Some dizziness; Weakness; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 23Jun2021 at 11:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included acquired hypothyroidism. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (EUTHYROX) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 02Jun2021 at 11:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Jun2021 at 17:00, the patient experienced achy muscles, especially near injection site, very fatigued, mild nausea, chills, flu like symptoms, feeling cold, dizziness and weakness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events achy muscles, especially near injection site, very fatigued, mild nausea, chills, flu like symptoms, feeling cold, dizziness and weakness was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Practically unconscious the first day and a half; fever; practically in immense pain from head to toe, including the kidneys./aches; practically in immense pain from head to toe, including the kidneys.; with chills like never before.; His knee and back felt as if someone shot a hole and left him there./back pain; His knee and back felt as if someone shot a hole and left him there./knee pain; This is a spontaneous report from a contactable consumer. A 21-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EW0217), via an unspecified route of administration on 21Jun2021 12:00 (at the age of 21-years-old) at dose 2, single in the left arm for COVID-19 immunisation. The patient has no medical history. The patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient's concomitant medications were not reported. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EW0186) received on 31May2021 at 13:00 in the left arm for COVID-19 immunisation. On 22Jul2021 11:00, the patient was practically in immense pain from head to toe, including the kidneys, and had fever. On 22Jul2021 11:00 the patient was practically unconscious from the first day and a half, with chills like never before. On the same day, on 22Jul2021 11:00, The patient's knee and back felt like as if someone shot a hole and left him there. They weren't sure if the patient was going to make it. The chills, fever, and aches left but the knee pain and back pain still sits with the patient until today. The events were assessed as serious due to disability or permanent damage. The patient was not given any treatment for the events. Outcome of the event unconscious was recovered on 23Jul2021 23:00, for back pain and knee pain was not recovered, and for other events was recovered on an unspecified date in 2021.   Follow-up attempts are completed. No further information is expected.
This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration at arm left on 11Feb2021 07:30 (Batch/Lot Number: Unknown as unable to locate or read the details; expiration: not reported) as single dose for COVID-19 immunization (at the age of 65 years and the patient was not pregnant). Medical history included known allergies: penicillin. The patient concomitant medications were not reported. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Feb2021 at 07:00, exactly one week after shot, the patient experienced body aches, then severe 3-day headache during which sudden onset diplopia began and had persisted to this day, almost 10 weeks later. No other cause of the diplopia has been determined after numerous scans, MRIs, blood texts, etc. The patient went to doctor or other healthcare professional office/clinic visit. The outcome for all the events was not recovered.   Follow up needed. Information on the lot/batch number has been requested.
Rash on chest, gave patient 10 mL of Benadryl, rash went away after given benadryl
All covered in hives/doctor said that it was the worse case of hives doctor had seen; Awful; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (All covered in hives/doctor said that it was the worse case of hives doctor had seen) and FEELING ABNORMAL (Awful) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced URTICARIA (All covered in hives/doctor said that it was the worse case of hives doctor had seen) and FEELING ABNORMAL (Awful). At the time of the report, URTICARIA (All covered in hives/doctor said that it was the worse case of hives doctor had seen) and FEELING ABNORMAL (Awful) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.   Patient took 2 medicines orally and 1 injection to treat symptoms .   Patient did not know what was taken but one of these was an antihistamine.
7 days later tested positive for the COVID-19 infection/Patient is not showing any symptoms; This is a spontaneous report from a contactable consumer (patient's mother).  A male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration on unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient's mother was asking in regards of her son who received first dose of the COVID-19 vaccine and 7 days later (the next Monday) tested positive for the COVID-19 infection, she wants to know if the patient could receive the second dose, is been 14 days since he tested positive with the PCR test. Patient is not showing any symptoms. Outcome of the events was unknown. As of 15Mar2021, the reporter stated that she was trying to obtain information about the 2nd dose. She confirmed, patient did receive the 2nd dose with no reactions.  Information on the lot/batch number has been requested.  Follow up (15Mar2021): New information received from the same contactable consumer (patient's mother) includes: event onset date details and confirmed that patient did receive the 2nd dose with no reactions. This is also a follow-up report to notify that the case 2021298800 and 2021025717 are duplicates. All subsequent follow-up information will be reported under manufacturer report number 2021298800.   Information on the lot/batch number has been requested.
3 weeks after tetanus booster, patient experienced progressive paresthesia and weakness to the point of paralysis in all 4 extremities. He was subsequently diagnosed with Guillain Barre syndrome.
I started feeling I had an appointment with my rheumatologist when I noticed the symptoms at about 11:30AM. I was feeling like I was coming down with the flu. I felt lethargic and did not want to eat to much. The symptoms lasted until that Sunday or Monday. This was around 4 days. I was achy and feverish. This gave me apprehension about getting the 4th dose of the vaccine which I shared those concerns with my doctor. With my heart thing, I worry about triggering another episode of Atrial Fibrillation. I rested and took Tylenol.
I have tremors throughout my body (like a low voltage shocking), nerve twitches in hands, arms, and legs,  legs feel extremely heavy and the left leg hurts 24-7, feet feel like the bottoms are burned, toes and fingers tingle at times and then feel numb at times, headaches with sharp pains going up the back of my head and through my forehead, explosive diarrhea, and trouble walking due to the left leg and left foot pain.
One week after my first shot (received on 9/06/21) I developed intermittent chest heaviness and being out of breath with minimal activity. I made a separate vaers report for that shot as the two shots were more than one month apart.  Unfortunately I did not equate those symptoms to the vaccine until receiving the second dose (for which this report is on and it was received 1/4/22), since after the second dose it was very clear that these symptoms were 100% from the vaccine as they both initially developed and then later worsened exactly 1 week after each shot.  One week after the second dose my chest heaviness worsened and was then daily, rather than intermittent. My being out of breath was also daily and significant with even basic activities of daily life, talking, singing in car, etc.  Worse then and now in situations where I have to be masked. It has changed my quality of life for the worse, but has improved some.  I am still far from my previous baseline. I am not out of breath as often now with talking or singing or walking (as long as it's a slow pace and a flat surface).  I still get severely out of breath when trying to walk fast, walk up stairs, or walk uphill.  I do intermittently still get out of breath from just talking. or doing basic activities.  Chest heaviness is now back to being intermittent, instead of daily, but can still be significant and both things are worrisome. I am now almost 7 months out from 2nd shot and I am starting to believe I will never get better.
Persistently intermittent high-grade fevers with associated chills since 4/14/2021. On 4/20/2021, patient reported to his PCP for further management, and blood workup did not show any acute abnormalities. On the morning of 5/5/2021, patient woke up with a 101F fever and appeared to be confused as per wife and niece, which prompted ED visit.